# Giuseppe Plazzi, M.D. – FDA Inspection, Mar 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/giuseppe-plazzi-md/3d1b8181-eba2-4280-8957-b3b3ae2be204
Source feed: FDA_Inspections

> FDA inspection 1235369 of Giuseppe Plazzi, M.D., March 15, 2024. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235369
- Company Name: Giuseppe Plazzi, M.D.
- Inspection Date: 2024-03-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1317562 - 2026-04-30
- FDA Inspection 1068227 - 2018-09-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/lakecha-n-lewis/39b6305d-2a9f-448b-9a14-e412b43c8522)

Company: https://www.keypedia.com/companies/giuseppe-plazzi-md/84105614-311b-4f97-89f4-e90027e88ee3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c